研究型论文(Original Research)：
[第一作者，First Author]
1. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway, Molecular Cancer, 2020, 19(1):166 (大类TOP1区, IF=41.444, 第一作者)
2. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1, Molecular Therapy, 2019, 27(2): 365-379 (大类TOP1区, IF=11.454, ESI高被引, 第一作者)
3. Targeting SKA3 suppresses the proliferation and chemoresistance of laryngeal squamous cell carcinoma via impairing PLK1-AKT axis-mediated glycolysis, Cell Death & Disease, 2020, 11(10): 919 (大类2区, IF=8.469, 第一作者)
4. Identification of miR-145-5p-centered competing endogenous RNA network in laryngeal squamous cell carcinoma, Proteomics, 2019, 6(21-22): e1900020 (大类2区, IF=3.984, 第一作者)
5. Mass Spectrometric Analysis Identifies AIMP1 and LTA4H as FSCN1 Binding Proteins in Laryngeal Squamous Cell Carcinoma, Proteomics, 2019, 19(21-22): e1900059 (大类2区, IF=3.984, 第一作者)
6. MicroRNA-204-5p inhibits invasion and metastasis of laryngeal squamous cell carcinoma by suppressing forkhead box C1, Journal of Cancer, 2017, 8(12): 2356-2368 (大类3区, IF=4.207，第一作者)
7. Fascin-1, Ezrin and Paxillin Contribute to the Malignant Progression and Are Predictors of Clinical Prognosis in Laryngeal Squamous Cell Carcinoma, Plos One, 2012, 7(11): e50710 (大类3区, IF=3.240, 第一作者)
[最终责任通讯, Corresponding Author]
9. Circular RNA circCORO1C promotes laryngeal squamous cell carcinoma progression by modulating the let-7c-5p/ PBX3 axis, Molecular Cancer, 2020, 19(1): 99 (大类TOP1区, IF=41.444, 通讯作者)
10. miR-1207-5p suppresses laryngeal squamous cell carcinoma progression by downregulating SKA3 and inhibiting epithelial-mesenchymal transition, Molecular Therapy-Oncolytics, 2021, 19(22):152-165. (大类2区, IF=7.2, 通讯作者)
11. Petroleum extract of Farfarae Flos alleviates nasal symptoms by regulating the Th1-Th2 cytokine balance in a mouse model of Allergic Rhinitis, International journal of medical sciences, 2021, 18(2): 555-563 (大类3区, IF=3.738, 通讯作者)
12. Mass spectrometry-based proteomic analysis of FSCN1-interacting proteins in laryngeal squamous cell carcinoma cells, IUBMB Life, 2019, 71(11): 1771-1784 (大类3区, IF=3.885, 通讯作者)
[共同通讯, Co-Corresponding Author]
13. Epidemiological Analysis of 1234 Cases of Laryngeal Cancer in Shanxi Province, China, Cancer control, 2021, 28:10732748211041236.(大类3区, IF=3.302, 共同通讯)
14. Alterations of bacterial communities of vocal cord mucous membrane increases the risk for glottic laryngeal squamous cell carcinoma, Journal of cancer, 2021, 12(13): 4049-4063 (大类3区, IF=4.207, 共同通讯)
15. Serum Exosomal miR-941 as a promising Oncogenic Biomarker for Laryngeal Squamous Cell Carcinoma, Journal of Cancer, 2020, 11(18): 5329-5344 (大类3区, IF=4.207，共通作者)
16. miR-424-5p Promotes Proliferation, Migration and Invasion of Laryngeal Squamous Cell Carcinoma, Oncotargets And Therapy, 2019, 12: 10441-10453 (大类3区, IF=4.147, 共通作者)
17. Astragali radix total flavonoid synergizes cisplatin to inhibit proliferation and enhances the chemosensitivity of laryngeal squamous cell carcinoma, Rsc Advances, 2019, 9(42): 24471-24482 (大类3区, IF=3.361, 共通作者)
18. Whole-Transcriptome Analysis of CD133＋CD44＋ Cancer Stem Cells Derived from Human Laryngeal Squamous Cell Carcinoma Cells, Cellular Physiology And Biochemistry, 2018, 47(4): 1696-1710 (大类2区, IF=5.5, 共通作者)
[共同第一作者, Co-First Author]
19. AlloDriver: a method for the identification and analysis of cancer driver targets, Nucleic Acids Research, 2019, 47(W1): W315-W321 (大类TOP1区, IF=16.971, 共同第一作者)
20. Enhanced endosomal escape by photothermal activation for improved small interfering RNA delivery and antitumor effect, International Journal of Nanomedicine, 2018, 13: 4333-4344 (大类2区, IF=6.4, 共同第一作者)
21. Identification and characterization of CD133＋CD44＋ cancer stem cells from human laryngeal squamous cell carcinoma cell lines, Journal of Cancer, 2017, 8(3): 497-506 (大类3区, IF=4.207, 共同第一作者)
22. Potential key molecular correlations in laryngeal squamous cell carcinoma revealed by integrated analysis of mRNA, miRNA and lncRNA microarray profiles, Neoplasma, 2016, 63(6): 888-900 (大类4区, IF=2.575, 共同第一作者)
23. Hsa-miR-301a-3p Acts as an Oncogene in Laryngeal Squamous Cell Carcinoma via Target Regulation of Smad4, Journal of Cancer, 2015, 6(12): 1260-1275 (大类3区, IF=4.207, 共同第一作者)
[其他位列作者, Co-Author]
24. LncRNA REG1CP promotes tumorigenesis through an enhancer complex to recruit FANCJ helicase for REG3A transcription, Nature Communications, 2019, 10(1): 5334(大类TOP1区, IF=14.919, 第六作者)
25. c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis, Nature communications, 2020, 11(1): 4980 (大类TOP1区, IF=14.919, 第六作者)
综述性论文(Review):
[通讯或共通讯, Co/Corresponding Author]
26. Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer, Molecular cancer, 2021, 20(1): 126 (大类TOP1区, IF=41.444, 共同通讯)
27. Fascin actin-bundling protein 1 in human cancer: Promising biomarker or therapeutic target?, Molecular therapy-oncolytics, 2021, 20:240-264 (大类2区, IF=7.2，通讯作者)
28. Crosstalk between RNA m6A modification and non-coding RNA contributes to cancer growth and progression, Molecular Therapy: Nucleic Acid, 2020; 22:62-71 (大类1区, TOP1区, IF=8.886, 通讯作者)
29. Non-coding RNAs in drug resistance of head and neck cancers: A review, Biomedicine & Pharmacotherapy, 2020, 127(2020): 110231 (大类2区, IF=6.529, 通讯作者)
30. Effect of HPV infection on the occurrence and development of laryngeal cancer: a review, Journal of Cancer, 2019, 10(19): 4455-4462 (大类3区, IF=4.207, 通讯作者)
31. Regulatory role and mechanism of m6A RNA modification in human metabolic diseases, Molecular Therapy - Oncolytics, 2021 , doi.org/10.1016/j.omto.2021.05.003 (大类分区2区, IF=7.2, 共同通讯)
32. Tumor microenvironment and immune-related therapies of Head and neck squamous cell carcinoma, Molecular therapy-oncolytics, 2021, 20:342-351 (大类2区, IF=7.2, 共同通讯)
知识产权(Patent & Copyright)：
1. 第一发明人, 一种细胞平板克隆形成图像采集仪, 2016.03.30, 中国, ZL 201520998317.9
2. 第一发明人, 一种抑制FOXC1基因表达的siRNA及其应用, 2015.07.08, 中国, ZL 201310651571.7
3. 第一发明人, 人微小RNA启动子甲基化扩增及测序引物及其应用, 2015.06.10, 中国, ZL 201310359969.3
4. 第一发明人, 一种针对人fascin-1基因的siRNA及其应用, 2015.04.22, 中国, ZL 201310004333.7
5. 第一发明人, 一种耳鼻咽喉头颈外科专用颞骨及头部解剖训练台, 2018.04.10, 中国, ZL 201611056422.6
6. 第一发明人, 一种耳鼻咽喉头颈外科专用颞骨及头部解剖训练台, 2017.09.29, 中国, ZL 201621277012.X
7. 第一发明人, 耳鼻咽喉头颈外科专用颞骨及头颈部解剖训练台, 2017.03.08, 中国, ZL 201630575793.X
8. 第一发明人, 用于火棉胶包埋全喉大体标本专用的包埋底盒, 2012.04.18, 中国, ZL 201010579358.6
9. 第一发明人, 智能正压恒温仿生式全自动鼻腔冲洗治疗仪, 2008.12.03, 中国, ZL 200720104850.1
10. 第二发明人, 可调节的琼脂糖凝胶回收切胶器, 2019.10.18, 中国, ZL 201930041826.6
11. 第二发明人, 一种尸头解剖固定架, 2019.02.19, 中国, ZL 201820029259.2
12. 第二发明人, 尸头解剖固定架, 2018.06.19, 中国, ZL 201830007713.X
13. 第二发明人, 一种Hsa-miR-145-5p试剂盒及其成熟体模拟物的应用, 2016.09.09, 中国, ZL 201310408755.0
14. 第二发明人, 一种带UV紫外线灯的离心管架, 2016.08.31, 中国, ZL 201620339275.2
15. 第二发明人, 全自动鼻腔冲洗治疗仪, 2014.12.31, 中国, ZL 201430176954.9
16. 第三发明人, 一种摇床, 2019.11.22, 中国, ZL 201920109376.4
17. 第三发明人, 一种可调节的琼脂糖凝胶回收切胶器, 2019.10.18, 中国, ZL 201920124174.7
18. 第四发明人, 一种慢病毒单质粒体内生物素化载体及制备方法, 2019.11.19, 中国, ZL 201610928951.4
19. 第四发明人, 细胞划痕实验辅助装置, 2019.11.05, 中国, ZL 201920134722.4
20. 第四发明人, 摇床, 2019.06.21, 中国, ZL 201930036349.4
21. 第四发明人, 一次性外耳道硅胶冲洗管, 2013.04.03, 中国, ZL201220484661.2
22. 第六发明人, 戴维氏开口器的软腭牵拉装置, 2015.04.29, 中国, ZL201310329412.5
23. 第六发明人, 戴维氏开口器的软腭牵拉装置, 2014.01.15, 中国, ZL201320464888.5
24. 第一权利人, 科研业务综合管理系统V5.0, 2016SR107789, 原始取得, 全部权利, 2016.05.17
25. 第一权利人, 科研综合业务云智慧管理系统, 2019SR0262022, 原始取得, 全部权利, 2019.03.19
26. 第二权利人, 实验室实验技能在线考试管理系统, 2019SR0947048, 原始取得, 全部权利, 2019.09.11
27. 第二权利人, 头颈肿瘤转录组与随访数据管理系统V1.0, 2019SR0807557, 原始取得, 全部权利, 2019.08.02
28. 第二权利人, 耳鼻咽喉-头颈外科患者随访系统V3.0, 2013SR049554, 原始取得, 全部权利, 2013.05.24
科研奖励(Scientific Reward)：
1. 第二获奖人, 喉鳞癌转录组差异网络构建与关键生物学功能调控机制研究, 山西省科学技术奖自然科学类一等奖, 2019.03
2. 省级优秀博士学位论文, 2015.01.21
3. 省级优秀硕士学位论文, 2011.03
4. 第一获奖人, 山西省优秀学术论文二等奖, 2016.08
5. 第一获奖人, 山西省优秀学术论文二等奖, 2016.08
6. 第二获奖人, 北京发明创新大赛铜奖, 2015.04
7. 第一获奖人, 北京发明创新大赛铜奖, 2015.04
8. 第一获奖人, 中央国家机关团工委首届先锋青年创新创意大赛一等奖, 2014.12
9. 第一获奖人, 第八届国际发明展览会“发明创业奖.项目奖”铜奖, 2014.11
10. 第一获奖人, 上海发明创新大赛二等奖, 2014.07